#fasttrackdesignation search results

There are ~150,000 patients suffering from EGFRi rash in the U.S. @azitrainc has received #FastTrackDesignation from the #FDA for #EGFRiAssociatedRash; plans to initiate a Ph1/2 clinical study in patients by mid 2025. #EGFRirash #Dermatology #PrecisionDerm #FastTrack

azitrainc's tweet image. There are ~150,000 patients suffering from EGFRi rash in the U.S. @azitrainc has received #FastTrackDesignation from the #FDA for #EGFRiAssociatedRash; plans to initiate a Ph1/2 clinical study in patients by mid 2025.
#EGFRirash #Dermatology #PrecisionDerm #FastTrack

📣The @US_FDA granted #FastTrackDesignation for AVB-001. Read full article & learn more about our #clinicaltrial at prnewswire.com/news-releases/…

AvengeBio's tweet image. 📣The @US_FDA granted #FastTrackDesignation for AVB-001. Read full article & learn more about our #clinicaltrial at prnewswire.com/news-releases/…

J. Robert Coleman, CEO of Codagenix, weighs on the importance of developing an #RSV #vaccine and talks about the company’s candidate CodaVax-RSV which received #fasttrackdesignation. Read more at @Contagion_Live -> contagionlive.com/view/fda-fast-…

Codagenix's tweet image. J. Robert Coleman, CEO of Codagenix, weighs on the importance of developing an #RSV #vaccine and talks about the company’s candidate CodaVax-RSV which received #fasttrackdesignation. 

Read more at @Contagion_Live -> contagionlive.com/view/fda-fast-…

The #FDA granted #FastTrackDesignation for quaratusugene ozeplasmid, with atezolizumab, in patients with extensive-stage small cell #lungcancer who did not develop #tumor progression after receiving atezolizumab and #chemotherapy: ow.ly/zE7j50Pu9aF #CancerResearch

OncologyTimes's tweet image. The #FDA granted #FastTrackDesignation for quaratusugene ozeplasmid, with atezolizumab, in patients with extensive-stage small cell #lungcancer who did not develop #tumor progression after receiving atezolizumab and #chemotherapy: ow.ly/zE7j50Pu9aF #CancerResearch

#BicycleTherapeutics Announces #FDA #FastTrackDesignation Granted to# BT8009 for the Treatment of Adult Patients with Previously Treated Locally Advanced or Metastatic #UrothelialCancer $BCYC 1stoncology.com/blog/bicycle-t…


Today, we announced that the @FDA has granted #FastTrackDesignation to our clinical program evaluating #pemvidutide, our novel #GLP1/Glucagon agonist, for the treatment of #NASH. Learn more: bit.ly/462jQQp.


#DualityBio Announces #DB1303 Granted #FastTrackDesignation by the U.S. Food and Drug Administration (#FDA) for the Treatment of Advanced, Recurrent or #Metastatic #EndometrialCarcinoma with #HER2Overexpression 1stoncology.com/blog/dualitybi…


Selinexor Receives Fast Track Designation From FDA For Myelofibrosis Treatment Read more at our website link in bio! #fasttrackdesignation #FDA #myelofibrosis #selinexor #xpovio #alzheimersdisease #cumulusneuroscience #diagnosis #digitalhealth #electroencephalogram #gadgets

thepharmtales's tweet image. Selinexor Receives Fast Track Designation From FDA For Myelofibrosis Treatment
Read more at our website link in bio!
#fasttrackdesignation #FDA #myelofibrosis #selinexor #xpovio #alzheimersdisease #cumulusneuroscience #diagnosis #digitalhealth #electroencephalogram #gadgets

We’ve launched REO 033, a Phase 2 study of #pelareorep + bevacizumab & FOLFIRI in second line KRAS mutant, microsatellite stable #ColorectalCancer. Following FDA #FastTrackDesignation, preliminary results are expected by year end 2026. Learn more: bit.ly/4aTrzG9

Oncolytics's tweet image. We’ve launched REO 033, a Phase 2 study of #pelareorep + bevacizumab & FOLFIRI in second line KRAS mutant, microsatellite stable #ColorectalCancer. Following FDA #FastTrackDesignation, preliminary results are expected by year end 2026. Learn more: bit.ly/4aTrzG9

.@EdgewiseTx Receives U.S. #FDA #FastTrackDesignation for EDG-5506 for the Treatment of #Duchenne Muscular #Dystrophy - check the link for more ow.ly/t1wS50QBfq6 #rarediseases and #orphandrugs

CheckOrphan's tweet image. .@EdgewiseTx Receives U.S. #FDA #FastTrackDesignation for EDG-5506 for the Treatment of #Duchenne Muscular #Dystrophy  - check the link for more ow.ly/t1wS50QBfq6 #rarediseases and #orphandrugs

THE FDA EXPEDITES THE DEVELOPMENT OF GSK’S VACCINE FOR GONORRHEA Read more at our website link in bio! . . . #fasttrackdesignation #FDA #gonorrhea #GSK #vaccine #pharmaindustry #pharmanews #pharmaupdates #news #pharmtales

thepharmtales's tweet image. THE FDA EXPEDITES THE DEVELOPMENT OF GSK’S VACCINE FOR GONORRHEA
 Read more at our website link in bio!
.
.
.
#fasttrackdesignation #FDA #gonorrhea #GSK #vaccine #pharmaindustry #pharmanews #pharmaupdates #news #pharmtales

🧵 Appeals Court Upholds FDA's Denial of Fast Track Designation for Vanda's Gastroparesis Drug #Fda #VandaPharmaceuticals #FastTrackDesignation #Gastroparesis #DrugApprovalProcess


We’ve launched REO 033, a Phase 2 study of #pelareorep + bevacizumab & FOLFIRI in second line KRAS mutant, microsatellite stable #ColorectalCancer. Following FDA #FastTrackDesignation, preliminary results are expected by year end 2026. Learn more: bit.ly/4aTrzG9

Oncolytics's tweet image. We’ve launched REO 033, a Phase 2 study of #pelareorep + bevacizumab & FOLFIRI in second line KRAS mutant, microsatellite stable #ColorectalCancer. Following FDA #FastTrackDesignation, preliminary results are expected by year end 2026. Learn more: bit.ly/4aTrzG9

The FDA has granted #pelareorep #FastTrackDesignation for the treatment of 2L KRAS-mutant, microsatellite-stable metastatic #ColorectalCancer based on it achieving 2-3X the efficacy benchmarks vs. standard of care. Read more in our press release: bit.ly/4ki6lED


✅ The @US_FDA granted #fasttrackdesignation to ZEN-3694 for use alongside abemaciclib in previously treated NUT carcinoma. ✅ This combination has improved responses vs BET inhibitors alone. ✅ZEN-3694 is being evaluated in a phase 1 trial. Read more 🗞️: onclive.com/view/fda-grant…


Radiopharm Theranostics (ASX: RAD) Gains FDA Fast Track for RAD101, Shares Jump 12.5% @TeamRadiopharm #FastTrackDesignation #ASX $RAD zurl.co/BPdII


There are ~150,000 patients suffering from EGFRi rash in the U.S. @azitrainc has received #FastTrackDesignation from the #FDA for #EGFRiAssociatedRash; plans to initiate a Ph1/2 clinical study in patients by mid 2025. #EGFRirash #Dermatology #PrecisionDerm #FastTrack

azitrainc's tweet image. There are ~150,000 patients suffering from EGFRi rash in the U.S. @azitrainc has received #FastTrackDesignation from the #FDA for #EGFRiAssociatedRash; plans to initiate a Ph1/2 clinical study in patients by mid 2025.
#EGFRirash #Dermatology #PrecisionDerm #FastTrack

🧵 Appeals Court Upholds FDA's Denial of Fast Track Designation for Vanda's Gastroparesis Drug #Fda #VandaPharmaceuticals #FastTrackDesignation #Gastroparesis #DrugApprovalProcess


No results for "#fasttrackdesignation"

Selinexor Receives Fast Track Designation From FDA For Myelofibrosis Treatment Read more at our website link in bio! #fasttrackdesignation #FDA #myelofibrosis #selinexor #xpovio #alzheimersdisease #cumulusneuroscience #diagnosis #digitalhealth #electroencephalogram #gadgets

thepharmtales's tweet image. Selinexor Receives Fast Track Designation From FDA For Myelofibrosis Treatment
Read more at our website link in bio!
#fasttrackdesignation #FDA #myelofibrosis #selinexor #xpovio #alzheimersdisease #cumulusneuroscience #diagnosis #digitalhealth #electroencephalogram #gadgets

📣The @US_FDA granted #FastTrackDesignation for AVB-001. Read full article & learn more about our #clinicaltrial at prnewswire.com/news-releases/…

AvengeBio's tweet image. 📣The @US_FDA granted #FastTrackDesignation for AVB-001. Read full article & learn more about our #clinicaltrial at prnewswire.com/news-releases/…

J. Robert Coleman, CEO of Codagenix, weighs on the importance of developing an #RSV #vaccine and talks about the company’s candidate CodaVax-RSV which received #fasttrackdesignation. Read more at @Contagion_Live -> contagionlive.com/view/fda-fast-…

Codagenix's tweet image. J. Robert Coleman, CEO of Codagenix, weighs on the importance of developing an #RSV #vaccine and talks about the company’s candidate CodaVax-RSV which received #fasttrackdesignation. 

Read more at @Contagion_Live -> contagionlive.com/view/fda-fast-…

Moleculin Biotech, Inc. received Fast Track Designation from the #FDA for the treatment of soft tissue #sarcoma (STS) lung metastases. Read more at ow.ly/UBZa50EestJ #fasttrackdesignation #regulatoryaffairs #drugdevelopment #biotech #cancer #oncology

biopharmaglobal's tweet image. Moleculin Biotech, Inc. received Fast Track Designation from the #FDA for the treatment of soft tissue #sarcoma (STS) lung metastases.
Read more at ow.ly/UBZa50EestJ
#fasttrackdesignation #regulatoryaffairs #drugdevelopment #biotech #cancer #oncology

THE FDA EXPEDITES THE DEVELOPMENT OF GSK’S VACCINE FOR GONORRHEA Read more at our website link in bio! . . . #fasttrackdesignation #FDA #gonorrhea #GSK #vaccine #pharmaindustry #pharmanews #pharmaupdates #news #pharmtales

thepharmtales's tweet image. THE FDA EXPEDITES THE DEVELOPMENT OF GSK’S VACCINE FOR GONORRHEA
 Read more at our website link in bio!
.
.
.
#fasttrackdesignation #FDA #gonorrhea #GSK #vaccine #pharmaindustry #pharmanews #pharmaupdates #news #pharmtales

We received #FastTrackDesignation from the U.S. #FDA for our non-genetically modified #placental derived NK #CellularTherapy in development for the treatment #AML. Learn more about the potential of our #CellularTherapy candidate here: bit.ly/3ewb8RU

celularity's tweet image. We received #FastTrackDesignation from the U.S. #FDA for our non-genetically modified #placental derived NK #CellularTherapy in development for the treatment #AML. Learn more about the potential of our #CellularTherapy candidate here:  bit.ly/3ewb8RU

前乙です! Enjinで32円抜き出来たけどナノキャリアでJCしましたw 〈4571〉ナノキャリアの材料は↓ NC-6300: FDAよりファスト・トラック指定を受けました。 #NanoCarrier #FastTrackdesignation #FDA nanocarrier.co.jp

fgYTpPDFFbqpLg4's tweet image. 前乙です!
Enjinで32円抜き出来たけどナノキャリアでJCしましたw
〈4571〉ナノキャリアの材料は↓
NC-6300: FDAよりファスト・トラック指定を受けました。
#NanoCarrier
#FastTrackdesignation
#FDA 
nanocarrier.co.jp

.@KrystalBiotech Receives #FDA #FastTrackDesignation for Inhaled #Oncology Candidate KB707 to Treat Solid #Tumors of the #Lung - check the link for more ow.ly/PqAY50QBf3R #rarediseases #orphandrugs

CheckOrphan's tweet image. .@KrystalBiotech Receives #FDA #FastTrackDesignation for Inhaled #Oncology Candidate KB707 to Treat Solid #Tumors of the #Lung - check the link for more  ow.ly/PqAY50QBf3R #rarediseases  #orphandrugs

We’re thrilled to share that #FDA has granted #FastTrackDesignation to NUZYRA® (omadacycline) for the treatment of pulmonary Nontuberculous Mycobacterial (NTM) disease caused by Mycobacterium avium complex (MAC) & Mycobacterium abscessus (MAB). More at: bit.ly/39FSEzO

ParatekPharma's tweet image. We’re thrilled to share that #FDA has granted #FastTrackDesignation to NUZYRA® (omadacycline) for the treatment of pulmonary Nontuberculous Mycobacterial (NTM) disease caused by Mycobacterium avium complex (MAC) & Mycobacterium abscessus (MAB). More at: bit.ly/39FSEzO

We are thrilled to announce we have received #FastTrackDesignation from the #FDA for our non-genetically modified #placenta derived NK #CellTherapy for the #treatment of adults with #GBM. Learn more: celularity.com/celularity-ann…

celularity's tweet image. We are thrilled to announce we have received #FastTrackDesignation from the #FDA for our non-genetically modified #placenta derived NK #CellTherapy for the #treatment of adults with #GBM. Learn more: celularity.com/celularity-ann…

There are ~150,000 patients suffering from EGFRi rash in the U.S. @azitrainc has received #FastTrackDesignation from the #FDA for #EGFRiAssociatedRash; plans to initiate a Ph1/2 clinical study in patients by mid 2025. #EGFRirash #Dermatology #PrecisionDerm #FastTrack

azitrainc's tweet image. There are ~150,000 patients suffering from EGFRi rash in the U.S. @azitrainc has received #FastTrackDesignation from the #FDA for #EGFRiAssociatedRash; plans to initiate a Ph1/2 clinical study in patients by mid 2025.
#EGFRirash #Dermatology #PrecisionDerm #FastTrack

We’re thrilled to share that the #FDA has granted #FastTrackDesignation to AD109, our investigational combination therapy that has the potential to be the first oral pharmacologic that treats #ObstructiveSleepApnea. Learn more: ow.ly/NUWa50JJsMn #OSA #sleepdisorders

apnimed's tweet image. We’re thrilled to share that the #FDA has granted #FastTrackDesignation to AD109, our investigational combination therapy that has the potential to be the first oral pharmacologic that treats #ObstructiveSleepApnea. Learn more: ow.ly/NUWa50JJsMn #OSA #sleepdisorders

We’ve launched REO 033, a Phase 2 study of #pelareorep + bevacizumab & FOLFIRI in second line KRAS mutant, microsatellite stable #ColorectalCancer. Following FDA #FastTrackDesignation, preliminary results are expected by year end 2026. Learn more: bit.ly/4aTrzG9

Oncolytics's tweet image. We’ve launched REO 033, a Phase 2 study of #pelareorep + bevacizumab & FOLFIRI in second line KRAS mutant, microsatellite stable #ColorectalCancer. Following FDA #FastTrackDesignation, preliminary results are expected by year end 2026. Learn more: bit.ly/4aTrzG9

Loading...

Something went wrong.


Something went wrong.